Target intelligence / Profile preview

NACHT and WD repeat domain containing 1 (NWD1)

Target
NWD1
Molecular classification
Other (STAND protein family; contains NACHT domain and WD40 repeats; NLR-related protein; not a typical receptor, enzyme, or ion channel)
01

Overview

NACHT and WD repeat domain containing 1 (NWD1) is a cytosolic protein classified within the STAND (Signal Transduction ATPases with Numerous Domains) protein family, characterized by the presence of a NACHT nucleotide-binding domain and multiple C-terminal WD40 repeats. Structurally and phylogenetically, NWD1 is related to both the NLR (NOD-like receptor) subfamily and Apaf1 (a key regulator of apoptosis). The protein is highly expressed in certain tissues, including the prostate and neural stem/progenitor cells. Functionally, NWD1 is a critical regulator of androgen receptor (AR) protein steady-state levels and activity, with its expression tightly correlated to prostate cancer progression and AR-mediated gene expression. It is upregulated by SRY-family transcription factors and essential for the maintenance of AR-dependent prostate cancer cell growth, in part through supporting PDEF, a transcription factor that co-regulates AR. Additional studies suggest roles in neuronal development, axonal growth, and possible contributions to cellular stress and apoptosis pathways, making it an emerging but atypical target involved in malignancy and neural biology

Other names
NACHT domain- and WD repeat-containing protein 1NWD1NACHT and WD repeat domain-containing protein 1NWD1_HUMAN
02

Mechanism of action

modulates androgen receptor levels by association, but no direct drug-targeted mechanism has been reported

03

Biological functions

Androgen receptor signaling modulationCell signalingAxonal growthNeural developmentPotential roles in apoptosis and cellular stress responsePossibly innate immunity
04

Disease associations

Cancer (notably prostate cancer)Potential neurological roles (suggested in neuronal lineage and seizure pathophysiology)
05

Safety considerations

none explicitly reported; functional modulation could theoretically impact androgen signaling or neural processes
06

Biomarkers

Prostate cancer progression (elevated NWD1 expression is associated with advanced stages)possible biomarker for androgen-driven gene expression

Beyond the preview

Go deeper on NACHT and WD repeat domain containing 1 (NWD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NACHT and WD repeat domain containing 1 (NWD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call